SDS Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with SDS Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with SDS Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with SDS Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SDS Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000007952 - NADPH oxidase 1

Gene

ENSG00000185187 - single Ig and TIR domain containing

Gene

ENSG00000175581 - mitochondrial ribosomal protein L48

Gene

ENSG00000125798 - forkhead box A2

Gene

ENSG00000127831 - villin 1

Gene

ENSG00000183291 - selenoprotein F

Gene

ENSG00000178828 - ring finger protein 186

Gene

ENSG00000090659 - CD209 molecule

Gene

ENSG00000121797 - C-C motif chemokine receptor like 2

Gene

ENSG00000124164 - VAMP associated protein B and C

  • Gene

    ENSG00000007952 - NADPH oxidase 1


  • Gene

    ENSG00000185187 - single Ig and TIR domain containing


  • Gene

    ENSG00000175581 - mitochondrial ribosomal protein L48


  • Gene

    ENSG00000125798 - forkhead box A2


  • Gene

    ENSG00000127831 - villin 1


  • Gene

    ENSG00000183291 - selenoprotein F


  • Gene

    ENSG00000178828 - ring finger protein 186


  • Gene

    ENSG00000090659 - CD209 molecule


  • Gene

    ENSG00000121797 - C-C motif chemokine receptor like 2


  • Gene

    ENSG00000124164 - VAMP associated protein B and C

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.